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ABSTRACT
Eukaryotes such as higher plants have evolved to produce a diverse 
range of low-molecular-weight compounds known as secondary 
metabolites or phytochemicals, that can be used as food and 
feed additives, flavours, fragrances, cosmetics, agrochemicals 
and pharmaceuticals. The chemical diversity of plants is more 
complex than any chemical library made by humans, and the plant 
kingdom therefore represents an enormous reservoir of valuable 
molecules just waiting to be discovered. There are approximately 
298,000 species of higher plants, less than 10% of which have been 
chemically characterized to any extent. The majority of plant species 
are found in tropical rain forests. Extracts and infusions containing 
natural products from plants have historically been a major source 
of pharmaceutical ingredients, often comprising mixtures of several 
bioactive compounds with complex synergistic effects. The first 
secondary metabolite isolated from plants was morphine (over 200 
years ago) and many other natural compounds have since become 
important pharmaceuticals in modern society. It is often difficult to 
find synthetic substitutes with the same efficacy and specificity as 
natural compounds. Consequently, molecules derived from plants 
make up a sizeable proportion of current high-value drugs, and 
also provide many new lead compounds for industrial applications. 
Many companies are undergoing a renaissance in their interest in 
plant-derived compounds, especially the pharmaceutical industry 
looking for new drugs, and the cosmetics industry which uses plant 
extracts, oils and even plant cell cultures in some products. The high 
structural diversity and complexity of secondary metabolites still 
pose technical challenges for a phytochemist since the chemical 
characteristics of the plant compounds vary to a very high degree, 
for example in the degree of polarity and solubility.  Typically 
such compounds accumulate at low levels in plant tissues and 
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production is strongly correlated to specific vegetative stages. 
Thus the process of finding, extracting, isolating and purifying 
these phytochemicals is time-consuming and can be a daunting 
and challenging task.  Further many plants that produce high-value 
secondary metabolites are difficult to cultivate or are endangered 
because of over-harvesting and deforestation activities.  However, 
the last decade has seen tremendous development in technology and 
the birth of new, innovative methods that are now accessible for use 
by the current generation of researchers.  In some cases, what was 
impossible to do then has become almost routine now.  Armed with 
these new advantages and strength, the continuous exploration of 
plant biodiversity, using novel and innovative bioassays to evaluate 
natural compounds for their beneficial effects, is therefore of great 
scientific, medical and bioeconomic importance.  
 In this inaugural lecture, some highlights of my journey and 
discoveries made, together with my colleagues and students that 
I have worked with over the last 15 years of natural products 
research, will be presented.  Our research endeavours which began 
with a mainly  reductionist perpective, in accordance with the 
then popular drug discovery approaches used by big pharmas and 
academic laboratories all over the world, has now mellowed into a 
more holistic approach, utilizing ‘omics’ technologies.  Sample size 
and loss of biological activity due to the reductionist approach of 
disturbing the inherent synergism of a plant metabolome, has always 
been a delimiting factor in phytochemistry studies.  We believe that 
systems biology, in particular metabolomics/metabonomics, holds 
greater promise in our efforts to gain a deeper understanding of a 
plant metabolome’s effects on a disease state or on other biological 
perturbations.  
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INTRODUCTION
“What is a Weed - A Plant whose Virtues have yet to be 
Discovered”
   Robert Frost
Plants are virtually an endless supply of potential cures for humanity. 
Historically,  plants have formed the oldest basis for medicines 
and inspired many new ones to treat many debilitating diseases 
and relieve human sufferings.  They have been used as medicinal 
agents, first only on a folkloric basis,  but as  chemists moved from 
myth and mystery to establishing basis using modern scientific 
methods, the true properties of natural extracts from plants began 
to be uncovered.   Many of the early discoveries are now backed 
with scientific basis and some have been developed into single 
agent drugs.  Notable examples of compounds from folkloric plants 
that have been particularly important for human medicine include 
morphine from Opium Poppy (Papaver somniferum), aspirin from 
the White Willow Tree (Salix alba vulgaris), tubocurarin from the 
Amazonia ‘curare’ (Chondrodendron tomentosum) and the famous 
vinca alkaloid duo, vinblastine and vincristine, from the Madagascar 
Periwinkle (Catharanthus roseus) (Figure 1).  
Figure 1 Amazonia curare Chondrodendron tomentosum (left) and 
Madagascar periwinkle Catharanthus roseus (middle), the botanical 
source of tubocurarin (muscle relaxant) and vincristine (anticancer), 
respectively
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 Novel bioactive phytochemicals are important feedstock 
for potential development of new pharmaceuticals and the rich 
biodiversity of the tropical forest plants holds great promise for the 
discovery of such compounds.  The reason for this can probably be 
explained by their high chemical diversity which is unsurpassed 
by any other approaches used in drug discovery and development. 
Bioactive phytochemicals serve as useful chemical leads, to be 
refined synthetically by a medicinal chemist who creates analogues 
with enhanced potency, with better selectivity or specificity, and 
without the unwanted adverse side effects.
 The approach to drug discovery using plants as a source has a 
historical justification i.e plants have consistently yielded important 
new pharmaceuticals.  It also has a chemical rationale in that the 
natural product molecules provide templates for drug design. 
Finally, the biochemical rationale of using plants as a source is 
based upon the accepted understanding that the co-existence of 
plants with other occupants within the same ecosystem demands 
that they produce an armemantarium of defense substances, many 
of which would most likely be of a novel phenotype.  It is the direct 
result of the natural selection during evolution and competition 
between the species that has produced many powerful, biologically 
active natural product compounds.  The challenge now for us as 
Earth dwellers is to protect, conserve and sustainably harvest the 
benefits it can provide to humanity.  
 The chemical diversity of plants is more complex than any 
chemical library made by humans, and the plant kingdom therefore 
represents an enormous reservoir of valuable molecules just waiting 
to be discovered. The detailed exploration of plant biodiversity 
and the use of novel and innovative bioassays to evaluate natural 
compounds for their beneficial effects is therefore of great 
scientific, medical and bioeconomic importance. Many companies 
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are undergoing a renaissance in their interest in plant-derived 
compounds, especially the pharmaceutical industry looking for 
new drugs, and the cosmetics industry which uses plant extracts, 
oils and even plant cell cultures in some products. However, 
many plants that produce high-value secondary metabolites are 
difficult to cultivate or are endangered because of over-harvesting. 
The chemical synthesis of plant-derived compounds is usually 
uneconomical because the complex stereospecific structures are 
difficult to replicate. Typically such compounds accumulate at 
low levels in plant tissues and production is strongly correlated to 
specific vegetative stages, which makes isolation time consuming 
and expensive. Sustainable and cost-effective production systems 
for high-value plant-derived compounds must therefore be 
developed, and the best outcome can be achieved by integrating 
creative and multidisciplinary approaches into more sustainable 
production chains featuring cutting-edge innovative technologies.
PHYTOCHEMICALS AND STRUCTURAL 
DIVERSITY 
Plants are like a chemical factory where a wide range of organic 
substances are manufactured. A plant cell produces two types 
of metabolites. The f irst, the primary metabolites, such as 
carbohydrates, proteins and lipids,   are directly involved in growth 
and metabolism.  The other type is the secondary metabolites which 
are the end products of primary metabolism, such as, alkaloids, 
sterols, terpenoids, flavonoids, saponins, lignins and tannins.  These 
secondary metabolites are not involved in the normal growth, 
development or reproduction of the plants, but are believed to 
function as a defense mechanism against predators, parasites and 
diseases.  Due to this, secondary metabolites are accumulated by 
plants cells in smaller quantities than primary metabolites.  Further, 
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their biosynthesis occurs only in specialized cells and at a particular 
development stage.  The distribution of these metabolites in  plants 
vary from one family to another.  As shown in Figure 2, secondary 
metabolites are not made via a single pathway.  Specific pathways 
biosynthesize different classes of compounds and the occurrence of 
the compounds may be restricted to a particular taxonomic group 
which forms the basis of the study of chemotaxonomy.  The high 
structural diversity and complexity of the secondary metabolites 
also mean that the chemical characteristics of these phytochemicals 
are going to be very different with respect to the degree of polarity 
and solubility.   Thus, the process of finding, extracting, isolating 
and purifying these phytochemicals can sometimes be a daunting 
and challenging task.  
Figure 2  Biosynthetic pathways to secondary metabolites
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APPROACHES IN NATURAL PRODUCTS 
RESEARCH
The use of natural products as a source of or as molecular templates 
for novel structures in drug discovery is still alive and well. 
Although combinatorial chemistry techniques have succeeded as 
methods of optimizing structures, it has  produced only one de novo 
new chemical entity (NCE), reported in the public domain, since its 
first entry into the drug discovery scene 25 years ago (Newman & 
Cragg, 2007).  In many areas of drug discovery research, specifically 
for cancer-treatment and new anti-infectives, natural products’ 
continued influence is very clear, as can be seen from the high 
number of ‘natural product mimics’ approved as drugs for these 
diseases.  This proves that the exploration of nature’s ‘treasure trove 
of small molecules’ for novel active agents that may serve as leads 
and scaffolds into much needed efficacious drugs, has not been 
exhausted and should in fact be further expanded.
 A major objective of  natural products research is the preclinical 
development of bioactive natural products and their analogues. 
Searching for lead molecules from plants will usually involve 
following a straightforward information-led chemotaxonomic 
approach or following leads from ethnobotanical or ethnomedicinal 
uses of the plant.   Often times too, the search for bioactive molecules 
is solely based on serendipity which results from curiosity driven 
random screening of plants extracts. In general, the more logical 
ethnomedicinal-led approach, where empirical information serves 
as a guide to select potential plants for study, seem to have produced 
better outcomes.  This approach involves developing and optimizing 
suitable functional assays and evaluation of the medicinal plant 
extracts  for the relevant biological activity.  Once activity is 
validated, a bioassay-guided approach is adopted in the isolation 
and purification of the active constituents before culminating in the 
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elucidation of the chemical structure and stereochemistry using high 
resolution spectroscopic methods, in particular Nuclear Magnetic 
Resonance (NMR) and Mass Spectroscopy.  
 The early part of the drug discovery process encompasses  lead 
identification right up to lead optimization, i.e determination of 
the structure-activity relationships (SARs) of the molecule.  Lead 
identification is made more efficient through the use of rational drug 
design which guides medicinal chemists in their decisions regarding 
the next logical synthetic step.  It combines knowledge and skills 
from the fields of cheminformatics, molecular modeling and 
structural bioinformatics and demands in-depth understanding of 
the physico-chemical properties of the three-dimensional molecule 
(Adam, 2005).  Meanwhile, lead optimization aims at enhancing 
the most promising compounds to improve effectiveness, diminish 
toxicity or increase absorption. Many of the technologies for lead 
discovery overlap with those for lead optimization as researchers 
attempt to incorporate the best drug characteristics early in the 
process.  In designing a drug, attempts are made to find a ligand 
(the putative drug) that will interact favorably with a receptor 
that represents the target site.  Based on the information that is 
available, either ligand-based or receptor-based molecular design 
methods may be used. The ligand-based approach is applicable 
when the structure of the receptor site is unknown but a series of 
compounds have been identified that exert the activity of interest. 
Using structurally similar compounds with high activity, with no 
activity and with a range of intermediate activities, the approach 
attempts to identify a pharmacophore via recognition site mapping 
prior to ligand design.  
 Meanwhile, the receptor-based approach applies when a reliable 
model of the receptor site is available, as from X-ray diffraction, 
NMR, or homology modeling. Ligands that will interact favorably 
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at the site are designed, aided by computational molecular docking 
experiments.  SAR is the relationship between the chemical or three-
dimensional structure of a molecule and its biological activity. The 
analysis of SAR enables the determination of the chemical groups 
responsible for evoking a target biological effect in the organism. 
This allows modification of the effect or the potency of a bioactive 
compound (typically a drug) by changing its chemical structure. 
Medicinal chemists use the techniques of chemical synthesis to 
insert new chemical groups into the biomedical compound and test 
the modifications for their biological effects. Further refinements via 
real and virtual experiments are then used to derive mathematical 
relationships between the chemical structure and the biological 
activity i.e quantitative structure-activity relationships (QSAR) 
that give greater insights into the molecular interactions that are 
expected to occur in the biological systems.
MOLECULE HUNTING IN THE RAINFOREST 
Systematic botanists  estimate that there are approximately 298,000 
species of higher plants (Lawrence, 1951; Mora et al., 2011).  About 
1%,  roughly 3000, has been utilized for food and of  these 3000, 
about 150 have been commercially cultivated. However, the vast 
majority of caloric intake derives from only 20 species of plants. 
These plants represent the basis upon which the world’s population 
is fed, representing a very narrow foundation supporting the world’s 
human population. On the other hand, less than 10% of the higher 
plants have been chemically characterized to any extent.  This is 
despite the fact that, approximately 10,000 of the world’s plants have 
documented medicinal use, and in modern medicine, roughly 150 
to 200 of these plant materials are incorporated into pharmaceutical 
applications (Newman and Cragg, 2012). This is still a very small 
percentage of all higher plants, i.e  “just the tip of the iceberg”. 
❚❘❘ 10
Discovering Future Cures: From Phytochemistry to Metabolomics
There are many more potentially important discoveries in the plant 
kingdom to be exploited for pharmaceutical applications.
 Meanwhile, it has been estimated that approximately half of the 
species of higher plants are found in the tropical forests of the world 
(Sanjay 2007).  Malaysia has 14,000 of those species in her tropical 
rainforest.  Years ago, Burkill (1935) had reported the medicinal use 
of 1,300 of these species.   It would not altogether be a surprise, if 
a similar inventory is carried out in the present time, that the real 
number of medicinal plants that could be found in the rainforest  is 
much higher.  Thus, the rainforest is a haven for phytochemists who 
are basically ‘molecule hunters’, in search of plants with compounds 
that challenge their structure elucidation skills and could be  future 
lead molecules for future development into something useful.  The 
remaining sections of this book attempt to give a brief account of 
the exploration and some of the discoveries made over the course 
of 15 years of research.
Resolving Ambiguity of Flacourtiaceae Species
My phytochemical journey began with several rainforest plants 
which, under the Cronquist’s classification, were classified as 
belonging to the family Flacourtiaceae (Chase et al., 2002).  Common 
Flacourtiaceae species include the chalmoogra (Hydnocarpus 
kurzii) and rukam fruit (Flacourtia rukam) trees (Figure 3).  This 
family of plants was regarded as a ‘dumping ground’ for odd and 
anomolous genera.  Therefore, the chemistry of these plants were 
unpredictable and presented a fertile field for research, holding 
great promise for discovery of interesting structures, just waiting 
to be identified.   Our interest to chemically investigate the plants 
was not purely to look for novel and bioactive metabolites, but 
to also enrich the chemotaxonomic knowledge surrounding this 
heterogenous family of plants.  Chemotaxonomy is the scientific 
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discipline of accumulating information on the distribution of 
secondary metabolites with a view of using this information to 
throw light onto systematic or phylogenetic relationships among 
extant taxa, usually of higher plants.
Figure 3 Some Flacourtiaceae species found in Malaysia; (from left) 
Hynocarpus kurzii, Flacourtia rukam, Scolopia spinosa
 As it turned out, our work on  Scolopia spinosa (Khozirah 
& Waterman, 1994a) and Homalium longifolium (Khozirah & 
Waterman, 1995; 1996) can be considered to be of significant value 
to the field of chemotaxonomy as it provided proof that these two 
genera shared similar chemistry and therefore are taxonomicaly 
related.  Of the novel metabolites obtained from them most 
proved to possess a central core of 2-(13-glucopyranosyloxy)-
5-hydroxybenzyl alcohol, the position of glycosylation being 
confirmed by NMR experiments which showed both the anomeric 
H-1’ of the sugar and H-7 of the benzyl alcohol coupling to C-2 
(Figure 4). The sugar moiety was generally partially esterified with 
usually benzoic acid and occasionally, a trans-para-coumaric acid 
in H. longifolium, or (S)-aleprolic acid in S. spinosa.  
 Further series of esterifications to C-7 of the benzyl alcohol 
added more variability to the structures.  Notable examples of 
the esterifying acids include 1-hydroxy-6-oxocyclohex-2-en-
l-carboxylic acid in scoloposide-D and a 1,2,3-trihydroxy-6-
oxocyclo-hexane-l-carboxylic acid in  scoloposide-E.  In a further 
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modification the 2-hydroxyl was esterified with the aleprolic acid 
esterifying group that is so common in S. spinosa.  Meanwhile H. 
longifolium elaborated C-7 esterifications with 1,2,6-trihydroxy-5-
oxocyclohex-3-en-l-carboxylic and isocoumarinic acids.  For the 
former, an X-ray study resolved the stereochemistry of the three 
hydroxyls, all on the same face of the cyclohexenoic acid with 
the 2 and 6 hydroxyls in a pseudoequatorial configuration and 
the 1-hydroxyl pseudoaxial.  In addition to this, several aberrant 
glycosides were also isolated with a unique C~5 unit linked to 
the glucose at C-1.  The origins of this moiety is still unsolved. 
Interestingly, S. spinosa and H. longifolium have now been 
transfered to Salicaceae, where other 2,5-hydroxybenzyl alcohol-
bearing genera such as Poliothrysis, Xylosma and Phyllobotryon 
are now placed.  As a family, the Flacourtiaceae is now defunct 
and many of its 800 species have been transfered to other families, 
notably, Salicaceae, Samydaceae and Achariaceae in the molecular 
phylogeny-based classification.  
 Another Flacourtiaceae studied, Casearia clarkei, yielded 
podophyllotoxin-type lignans as major constituents (Khozirah 
and Waterman, 1994b),   It did not elaborate any of the previous 
glucosides or the typical diterpenoids nor coumarins associated with 
the genus. This finding was rather unexpected since this class of 
lignans are characteristic constituents of the Podophyllum species 
(Berberidaceae), better known as the American Mayapple.  The 
anticancer drugs, etoposide and teniposide, used in  chemotherapy 
for lung cancer, lymphomas and genital tumors, were inspired 
from this classs of lignans.  At the moment C. clarkei has still to 
be reclassified to a new family.
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Figure 4 Glucosides of 2,5-hydroxybenzyl alcohols isolated 
from Homalium longifolium and Scolopia spinosa (left) and 
podophyllotoxins from Casearia clarkei
 The knowledge and experience gained from working on the 
Flacourtiaceae provided a platform that launched me into the rest 
of my forays into the structural world of secondary metabolites. 
Together with a band of ‘molecule hunters’ consisting of research 
associates and students of the Laboratory of Natural Products of the 
Institute of Bioscience, we continued the search for novel and new 
structures that could be lying in wait in the dense and rich tropical 
rain forests of Malaysia which included the  Endau Rompin State 
Park and Royal Belum Forest Reserve. Highlights of some of our 
findings are presented in the following sections.  
Cytotoxic Xanthones of Garcinia 
Garcinia is the largest genus of the Guttiferae family.  They are 
usually small to medium dioecious fruit trees, characterized by a 
hard timber and the bark typically exudes a sulphur-yellow latex. 
Several species are famous for their edible fruits  such as the 
‘manggis’ (G. mangostana) and ‘asam gelugor’ (G. atroviridis) in 
Malaysia, and the ‘asam kandis’ (G. cowa) in Indonesia.  The barks 
of several species are also the source of gamboges, a natural yellow 
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pigment used in dyeing.  Ethnomedicinally  certain Garcinia species 
are used to heal wounds, skin diseases or used internally to treat 
bilious conditions, diarrhea and dysentery (Burkill, 1966).  Fifty 
of the 400 species of Garcinia distributed within the palaeotropical 
regions are found in Malaysia and many of them are endemic 
(Willis, 1973; Whitmore, 1983).  Chemotaxonomically, Garcinia 
is known to be a prolific producer of cytotoxic xanthones, of which, 
the chemical structures range from simple to the more complex 
caged- and phloroglucinol-types (Sultanbawa, 1980; Bennet & 
Lee, 1989).  Caged xanthones and phloroglucinols represent a 
challenging class of natural products in terms of both  isolation 
and characterization.  The total synthesis of the caged structure 
remains one of the unconquered challenges of organic synthesis 
which is still being pursued by many medicinal chemistry groups 
due to their potent antitumour activity.
 During the course of our exploration of tropical rainforest 
species we collected and screened a number of Garcinia species for 
cytotoxity against several cell-lines.  From these, several species i.e 
G. cantleyana (Figure 5), G. penangiana, G. urophylla and G. cowa, 
were found to be consistently active in the bioassays, which fueled 
our interest to subject them to further scrutiny of their bioactive 
constituents.  Chromatographic separation and isolation of the 
secondary metabolites yielded a whole series of polyprenylated and 
caged-xanthones as well as depsidones.  Full characterization of the 
novel structures made extensive use of NMR and mass spectroscopy. 
15 ❘❘❚ 
Khozirah Shaari
Figure 5  The leaves, bark and fruit of Garcinia cantleyana
 The leaves and bark of the G. cantleyana yielded several new 
caged-xanthonoids cantleyanone A to D and 7-hydroxyforbesione, 
in addition to the common deoxygaudichaudione A and 
gaudichaudione H (Figure 6).  The prenyl moieties on the non-caged 
section of these xanthonoids were in the free form or  oxidized to 
the dihydrobenzofuran or benzofuran moieties (Khalid et al., 2007). 
The biosynthetic pathway for the formation of cantelyanones B, 
D and F from gaudichaudione H were also proposed (Figure 7). 
Caged xanthones were also obtained from G. urophylla viz the 
new 7-hydroxydesoxymorellin together with  gaudichaudione H. 
Other than these, polyprenylated xanthones were also a common 
feature of all three species.  These included penangianaxanthone, 
macluraxanthone C, gerontoxanthone C and  cudratricusxanthone 
H (Rozida et al., 2007; Mat Lip et al., 2009) 
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Figure 6  Caged xanthones and polyprenylated xanthones from 
Garcinia species 
(1-4) Cantleyanones A to D, (5) 7-hydroxyforbesione, 
(6) 7-hydroxydesoxymorellin, (7) penangianaxanthone, (8) 
cudratricusxanthone H, (9) gerontoxanthone C, (10) macluraxanthone C
Figure 7 Proposed biosynthetic pathway of cantleyanones B, D and F 
from gaudichaudione H
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 As we had anticipated, many of the xanthones, particularly, 
the caged-xanthonoids tested significantly positive for cytotoxity 
against several cancer cell lines.  A structure-activity-relationship 
(SAR) analysis of the caged-xanthones clearly revealed that caged 
ring-B, a peri-hydroxyl group on ring-A, were an essential structural 
feature for bioactivity. This important finding was in accordance 
with other hypotheses (Cao et al., 1998; Mackeen et al.,  2000). The 
C8-8a double bond was also thought to be important for bioactivity 
(Zhang et al., 2004). However, as indicated by the weak cytotoxic 
activity exhibited by cantleyanone A, prenylation on C-2, appeared 
to  significantly reduce the cytotoxic activity of these xanthones. 
Further work on these complex xanthones was not pursued due 
to the limited quantities that were successfuly isolated from their 
natural sources.  Sadly, this is a reality which is a delimiting factor in 
natural products research. Total synthesis or other creative methods 
of obtaining adequate material for further biological and preclinical 
investigations are the obvious answer to this since sourcing from 
nature is just not sustainable in the long term.
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Saponins and Sapindaceae
The Sapindaceae, vernacularly known as the Soap-Nut family, is 
a family of plants that elaborates saponins as its most abundant 
secondary metabolites.  It is also famous for the edible fruits from 
some of its species such as Nephelium lappaceum Linn. (rambutan), 
N. mutabile Bl. (pulasan), N. malaiense Griff. (mata kucing) and 
Litchi chinensis Sonn. (litchi) (Hsuan, 1969). Our study focused on 
one of its lesser known genus, Xerospermum.  Six Xerospermum 
species, collectively known as ‘rambutan pachat’, were recorded 
in Malaysia but during our collection trips we found only two i.e. 
X. noronhianum and X. laevigatum (Corner, 1988).  The fruits of 
the species are also edible, the pulp sweet and pleasant although 
rather scanty.  An infusion of the pulped stone of ‘rambutan pachat’ 
is prescribed as a drink to cure very severe or ‘griping’ stomach 
pains, and a decoction of the leaves is used if the previous treatment 
fails (Burkill, 1966). We were however not able to find any records 
of chemical or biological studies on the Xerospermum species. 
Our interest in the genus was based on the positive results shown 
by its aqueous methanolic extracts in a preliminary screening for 
anti-acetylcholinesterase and anti-butyrylcholinesterase activities. 
These two enzymes are implicated in Alzheimer’s disease. 
  The word “saponins” implies a group of soap-like natural 
surfactants which form long-lasting bubbles on shaking of an 
aqueous solution.   This chemical definition is a general term for 
surface-active glycosides of triterpenoids and steroids (triterpenoidal 
saponins and steroidal saponins). Saponins are characterized by a 
skeleton derived from the 30-carbon precursor, oxidosqualene, 
to which glycosyl residues are attached (Vincken et al., 2007). 
Saponins having one sugar moiety are called monodesmosides, and 
those having two sugar moieties at different positions are called 
bisdesmosides (or bidesmosides) (Ikan, 1999).  
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 The separation and characterization of saponins are especially 
challenging, as are other similar very polar metabolites.  It demands 
strong technical skills, excellent chromatographic facilities and 
high-end spectroscopic instruments.  More often than not, strong 
perseverance on the part of the researcher will also be needed in 
solving the many technical difficulties that will arise.  We were 
lucky to have such a student to carry out the tasks of purifying 
and characterizing the Xerospermum saponins.  Her conscientious 
efforts succeeded in purifying twenty compounds from the plant 
which proved to be long and tedious.  Extensive use of 1D and 2D 
NMR spectroscopy were used to elucidate the atom connectivities of 
the triterpenoids and sponins, while LC-MS/MSn was employed to 
determine the molecular weights and sequences of sugar linkages in 
the bidesmosides (Tan et al, 2008).  These compounds, consisting of 
a variety of triterpenoids, flavonoid glycosides, phenolic acids and 
three bidesmosidic oleanane saponins i.e xerospermoside A, B and 
C (Figure 8), were the constituents present in the plant extract which 
tested positive for anti-cholinesterase and anti-butyrulnesterase, two 
enzymes implicated for Alzheimer disease.  Although the extract 
was originally potent, the compounds were moderate or inactive 
when tested individually.  This was not surprising as it is well known 
that the total biological effect of a plant could be due to synergistic 
effects.  Synergism is a positive interaction created when two or 
more substances combine and exert an effect that is more than the 
sum of their individual effects (Aiyegoro and Okoh, 2009).
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Figure 8  Xerospermosides and various triterpenoids from 
Xerospermum noronhianum
The Five-leaf Chaste-Tree and Gouty Pains
Vitex negundo is a popular medicinal plant in many Asian countries. 
Known as the five-leaved chaste tree, juice made from its purplish 
colored young leaves commonly serves as a treatment for sprained 
ankles, arthritic pain and similar injuries (Burkill, 1966).  The 
leaves produce a cooling effect that eases pain and swelling and are 
therefore  used in aromatic baths.  The Malays also use the species 
as an ulam and for culinary purposes where the young leaves are 
an essential ingredient for preparing ‘nasi lemuni’, a traditional rice 
dish.  In herbal medicine, V. negundo is regarded as an effective 
analgesic herb which alleviates pain and reduces edema.   
	 A	methanolic	extract	prepared	in	our	lab	tested	significantly	
positive	 in	 our	 antioxidant	 assays,	 giving	 more	 than	 95%	
❚❘❘ 22
Discovering Future Cures: From Phytochemistry to Metabolomics
inhibition	in	both	the	1,2-diphenyl-2-picrylhydrazyl	(DDPH)	and	
xanthine	oxidase	superoxide	(XOD)	scavenging	assays,	at	a	test	
concentration	of	250	mg/ml	sample.		Xanthine	oxidase	(XO)	is	the	
enzyme	that	catalyzes	the	conversion	of	hypoxanthine-xanthine-uric	
acid,	which	are	the	terminal	biochemical	reactions	of	the	purine	
degradation	pathway.	Therefore,	any	defects	in	purine	metabolism	
results	in	an	increase	in	the	level	of	uric	acid.	This	eventually	leads	
to	the	deposition	of	sodium	hydrogen	urate	monohydrate	crystals,	
from	the	hyperuricaemic	body	fluids,	in	joints,	resulting	in	gout,	
the	most	common	cause	of	inflammatory	arthritis	in	men	over	the	
age	of	40	years.		
 With our interest now triggered we pursued this bioactivity 
in the extract  further in a bioassay-guided approach, to isolate 
the secondary metabolites that might be responsible for the pain-
relieving properties.   Interphasing chromatographic separation and 
bioassaying the resultant column fractions repeatedly guided the 
isolation of several metabolites from the bioactive column fractions. 
The metabolites consisted of flavonoids, iridoids and lignans 
(Figure 9).  The XOD scavenging property of the metabolites was 
particularly interesting as it indicated the metabolites that could be 
responsible for the pain-relieving activity (Table 2).  Although the 
flavonoid luteolin showed  more potent activity in the antioxidant 
assays,  the overall bioactivity of the whole plant extract may have 
been due to synergy with the iridoids since these metabolites were 
also active in the XOD scavenging assay.  Incidentally, V. negundo 
and luteolin have also been reported to reduce uric acid levels, 
hence the plant’s use in alleviating gouty arthritic pain.  Our study 
served to add more evidence and support to these findings.  
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Figure 9   Iridoid	glucosides,	flavonoids	and	lignans	from	Vitex 
negundo	(1)	luteolin,	(2) isoorientin,	(3) luteoline-3-O-glucoronide,	(4)	
agnuside,	(5)	2-p-hydroxybenzoyl mussaenosidic acid,	(6)	isovitedoin	
A,	(7)	vitedoin	A,	(8)	vitrofolal	E,	(9)	negundins
Table 2  Inhibitory effects of the selected compounds of Vitex negundo 
on xanthine oxidase, DPPH radical and  XO superoxide scavenging  
activities
Compound
% inhibition
Xanthine 
oxidase (XO)
(100 mg/ml)
DPPH 
radical 
scavenging 
(250 mg/ml)
XO 
Superoxide 
scavenging
(250 mg/ml)
Luteolin 98.20	+	0.02 98.45	+ 0.02 100.00	+ 0.01
Isoorientin 46.39	+ 0.26 93.15	+ 0.02 90.45	+ 0.02
Agnuside 59.90	+ 0.25 94.52	+ 0.01 71.57	+ 0.01
Isovitedoin A 66.45	+ 0.20 96.71	+ 0.01 71.40	+ 0.01
2’-p-	hydroxybenzoyl	
mussaenosidic acid 22.02	+ 0.32 9.14	+	0.04 65.83	+	0.02
Allopurinol 92.80	+ 0.21 - -
Ascorbic Acid - 98.09	+ 0.02 85.65	+	0.01
All values are mean + S.D. 
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Chemical Marking Kachip Fatimah
Labisia pumila is the Latin name for the popular malay herb ‘kacip 
Fatimah’.  The estrogenic properties of L. pumila are very well 
known and have been, to a certain extent, supported by numerous 
biological studies (Jamal et al., 1998).  L. pumila has long been 
used in traditional medicine by the indigenous communities in the 
Malay archipelago, for treating pre- and post-partum complications, 
menstrual disorders, dysentery, rheumatism and flatulence,  in 
addition to being used as a health tonic to regain vigor (Jaganath, 
2000). In recent years, commercial products containing this 
herb have emerged in the Malaysian market for the purpose of 
enhancing vitality and libido (Latiff, 1997; Singh et al., 2009). 
The popularity of the herb provided an impetus for studies on 
the biological properties of the herb viz. antibacterial (Karimi 
et al., 2011, anti-inflammatory (Ibrahim et al., 1996; Rasadah et 
al., 2001), antioxidant (Mohamad et al., 2009), anti-ageing (Choi 
et al., 2010) and cardioprotective (Mohamad and Nazaimoon, 
2009).  Yet, very little is  known about the phytochemistry of sucn 
an important medicinal species.  This gap in  information and the 
medicinal importance as well as its economic promise, prompted 
our investigation of its uncharted secondary metabolites.  
 Comprehensive phytochemical investigation on L. pumila leaf 
material revealed it to contain alkylresorcinols and 1,4-benzoquinone-
phenol dimers (Figure 10), as characteristic constituents, plus other 
common metabolites such as triterpenoids, flavonoids, flavans, 
phenolic acids and sterols.  The structures of these compounds 
were established on the basis of 1D and 2D NMR spectroscopy 
techniques and mass spectrometry.   In the characterization of the 
dimers, labisiaquinones A and B, a slight problem was encountered 
in the double bond assignments for the alkyl chains.  This was 
resolved by chemical derivatization (ozonolysis) followed by 
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ESIMS analysis of the reaction products (Figure 11).  Several of 
the alkylresorcinols, were significantly cytotoxic towards the human 
prostate (PC-3), colon (HCT-116) and breast (MCF-7) cancer cell 
lines.  The actoxyresorcinols exhibited strongest cytotoxic activity 
at equipotent submicromolar growth inhibition (GI
50
) in the tested 
cancer cell lines, in fact more potent than doxorubin (Table 3).  More 
importantly, they exhibited cancer-type selectivity against PC-3 and 
HCT-116 cells at the TGI and LC
50
 levels. The 1,4-benzoquinone 
dimers however  were not cytotoxic.  Nevertheless, similar long 
chain alkylphenols/benzoquinones  (monmeric, dimeric, and 
conjugated forms) have been reported from other genera in 
the Myrsinaceae family viz. Ardisia, Embelia and Maesa.  The 
1,4-benzoquinone dimers and alkylresorcinols will be useful as 
chemical markers in the chemical fingerprinting of L. pumila raw 
material and extracts.  These are much needed for quality control 
purposes of the myriad of commercial products containing ‘kachip 
Fatimah’ that are flooding the Malaysian market.
Figure 10  Labisia pumila and its chemical markers: Labisiaquinone 
A (1), Labisiaquinone B (2), 5-(pentadec-10Z-enyl)resorcinol 
(3), 1-O-methyl-6-acetoxy-5-(pentadec-10Z-enyl)resorcinol 
(4), 5-pentadecylresorcinol (5), 1-O-methyl-6-acetoxy-5-
pentadecylresorcinol (6)
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Figure 11  Alkenyl resorcinol (3d), alkyl benzoquinone (3e) cation 
fragments and aldeyde adduct formation by ozonolysis of an acetylated 
analogue of labisiaquinone B
Table 3  In vitro cytotoxic activity of acetoxy resorcinols 4 and 6 
towards cancer cell lines
Compound
Growth inhibitory parameters (mM)
Cell line GI
50
TGI LC
50
1-O-methyl-
6-acetoxy-5-
(pentadec-10Z-enyl)
resorcinol (4)
PC-3 0.3 + 0.0 1.2 + 0.0 8.0 + 1.7
HCT-116 0.3 + 0.0 1.0 + 0.1 7.7 + 6.4
MCF-7 0.4 + 0.1 15.7 + 2.1 41.3 + 2.3
1-O-methyl-
6-acetoxy-5-
pentadecylresorcinol 
(6)
PC-3 0.4 + 0.1 1.6 + 0.4 10.0 + 4.4
HCT-116 0.3 + 0.0 1.6 + 0.3 12.0 + 8.7
MCF-7 0.5 + 0.1 15.0 + 1.7 40.0 + 0.0
Doxorubin PC-3 0.7 + 0.1 4.2 + 0.2 20.0 + 0.5
HCT-116 0.6 + 0.1 2.0 + 0.2 5.0 + 0.5
MCF-7 0.6 + 0.1 1.9 + 2.2 5.5 + 0.5
PC-3: human prostate, HCT-116: colon,  MCF-7: breast. The cells were treated for 96 h 
with at least four different concentrations of compounds ranging from 0.1 to 100 lM. MTT 
assay (Mosmann, 1983) was used to calculate GI50, TGI and LC50 values (expressed in 
lM). Values are mean of three independent experiments and errors represent the SD values. 
a Doxorubicin was used as a positive control
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Hanging Out with Clubmosses and Filmy Ferns 
Club mosses (Lycopodiaceae) and filmy ferns (Hymenophyllaceae) 
are two primitive sub-divisions of vascular plants, native to the 
moist tropical mountains and northen hemisphere.   The club moss 
is a small sized,  low growing evergreen plant, possessing a ground 
hugging stem that can reach lengths of up to four feet when fully 
grown.  It is characterized by dense spirals of yellow green colored 
leaves.  Meanwhile, ferns are distinctive-looking plants with many 
leaf stalks growing from a central base. Hundreds of leaflets grow 
along the stalks,  further divided into subleaf or pinnules in some 
species.   Depending on species, these fronds can grow up to 12 
feet long, as in tree ferns, or only a fraction of an inch, as in filmy 
ferns.  Ferns and lycophytes were long considered as mystical plants, 
because people could not understand how they could reproduce 
without ever producing a flower, a fruit or a seed.  They are naturally 
beautiful visually appealing plants and  many are sold as garden 
hanging plants.  Club mosses and ferns have many medicinal uses, 
some dating way back to ancient times.  Disorders like kidney stones 
and urinary tract infections were once treated using remedies that 
contained both the spores and the whole club moss plant, while the 
leaves and rhizomes of the maidenhair fern are used for coughs, 
asthma and pleurisy.
 Our phytochemical study on several Lycophytes (Huperzia 
spp) and the filmy fern (Hymenophyllum javanicum Spreng) 
yielded several novel/new and known compounds.  The work was 
very challenging due to the small amount of material that could 
be obtained for the species from our forages into the tropical rain 
forest.  Thus the identification of these structures was carried out 
in collaboration with our Japanese counterparts who are equipped 
with better high end research facilities.  H. javanicum elaborated 
hemiterpene glucosides i.e Javanicosides A-D, the hemiterpene 
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being a 2-hydroxymethyl-3,4-dihydroxy-1-butene (Figure 12). The 
glucose moiety was esterified on various positions by phenylacetic 
acid derivatives, which is responsible for the hot and bitter taste of 
the fern (Figure 13).  
Figure 12  Javanicosides from Hymenophyllum javanicum
Figure 13 1H NMR spectrum Javanicoside D and selected correlations 
observed in the 2D NMR HMBC experiment run at 500MHz in 
deuterated methanol
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 The club mosses (Huperzia carinata and H. nummularifolia) 
(Figure 14) showed signif icant inhibition of the enzyme 
acetylcholinesterase (AChE).  Further phytochemical investigation 
however yielded mainly serratane triterpenoids.  The presence of 
minor amounts of lycopodium-type alkaloids, notably huperzine A, 
was detected via LCMS/MS in H. carinata (Figure 15).  Huperzine 
A is a highly specific and potent inhibitor of acetylcholinesterase 
(AChE). Its presence in the extract explained the anti-AChE activity 
shown by the extract.  The biological activity of the serratanes has 
yet to be tested.
Figure 14  Some phytochemical constituents isolated from Huperzia 
species; H. carinata (left), H. nummularifolia (right)
Figure 15  LCMS qualitative and quantitative analyses of Huperzine A 
in methanolic extract of Huperzia carinata
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Discovering tHGA, a Natural LO Inhibitor
Late in 2002, a young and enthusiastic Indonesian student 
approached our group to pursue her Masters in Natural Products 
Chemistry.  She brought with her several local herbs to screen 
for her project.  Among them was a, then, little known ‘ulam’, 
which the locals called ‘setenggek burung’, in Latin Melicope 
ptelefolia Champ ex Benth (syn. Melicope lunu-akenda).  Among 
the traditional uses of the species were as a digestive and an 
appetizer (Loi, 1977) and to treat menstrual pains and for healing 
wounds, fever and rheumatism (Perry & Metzger, 1980).   The 
literature reported fungicidal (Kumar et al., 1990) and antibacterial 
(Manandhar et al., 1985; Rasadah & Zakaria, 1988) properties but 
there were no studies to support its use in alleviating inflammation. 
 
Figure 16  Melicope ptelefolia Champ ex Benth aerial parts and flowers 
(left).  Chemical structure of 2,4,6-trihydroxygeranylacetophenone or 
tHGA (right)
 The  leaf crude extract and solvent fractions of the species 
were subjected to preliminary screening for antioxidant and 
anti-inflammatory activities.  Although both the hexane and 
dichloromethane fractions were strongly antioxidant, it was the 
activity of the dichloromethane fraction in the lipoxygenase (LO) 
enzyme inhibition assay that caught our interest due to its direct 
relevance to inflammation and asthma.  
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 LO is a group of closely related non-heme, iron containing 
dioxygenases catalyzing arachidonic acid metabolism.  The 
enzyme inserts molecular oxygen at the fifth carbon, forming 
5-hydroxyeicosatetraenoic acid (5-HETE). It then catalyzes a 
dehydration reaction, forming the unstable epoxide intermediate, 
leukotriene (LT) A4 which is then further metabolized to cysteinyl 
leukotrienes (CysLTs) by LTC4 synthase (Dahlén, 2006).  It is 
beneficial to suppress production of CysLTs because these lipid 
mediators exhibit proinflammatory characteristics whereby they 
have been demonstrated to promote airway eosinophilia, increased 
mucus hypersecretion and potent bronchoconstriction and tissue 
remodeling in asthmatic individuals (Busse and Kraft, 2005).   Over 
the last decade, LO inhibitors and leukotriene (LT) antagonists 
have become targets for rational drug design and discovery of 
mechanism-based drugs for treating chronic inflammatory diseases 
such as allergic asthma, psoriasis and rheumatoid arthritis.
 Encouraged by these early findings, our group embarked on 
an exhaustive phytochemical investigation of the  plant which 
resulted in the isolation and characterization of twenty secondary 
metabolites from the species	 (Khozirah et al., 2006 & 2011a; 
Abas et al., 2006).  More significantly, utilizing a bioassay-guided 
approach, our efforts culminated in the identification of a class 
of prenylated acylphloroglucinols, as the bioactive constituents 
responsible for the LO inhibition, in particular 2,4,6-trihydroxy-
3-geranylacetophenone (tHGA). This small molecule significantly 
inhibited human PBML 5-LO product synthesis,  specifically 
suppressing the formation of CysLTs with an IC
50
 value of 1.80 
mM, with no cell toxicity effects (Khozirah et al., 2011b).  Since 
tHGA showed moderate DPPH activity and tested negative as a 
metal-chelator, it seemed that tHGA possibly acted via a competitive 
(non-redox) mechanism in its interaction with 5-LO. Non-redox 
type LO inhibitors have been shown to have fewer side effects than 
redox or iron-chelating agents (Dahlén, 2006). 
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Figure 17  Overview of pathways involved in biosynthesis of 
leukotrienes. Arachidonic acid is released from cellular phospholipids 
by phospholipase A
2
 (PLA
2
) and converted by 5-LO and FLAP to 
LTA
4
. LTA
4
 is transformed by either LTA
4
H or LTC
4
S into two classes 
of compounds, LTB
4
 and cysteinyl leukotrienes (LTC
4
, LTD
4
, and 
LTE
4
). Cysteinyl leukotrienes bind two distinct receptors, CysLT
1
 and 
CysLT
2
. LTB
4
 acts at specific receptors that are designated BLT
1
 and 
BLT
2
 (GGT: γ-glutamyl transpeptidase, DP: dipeptidase). Leukotriene 
modifiers include both 5-lipoxygenase inhibitors and cysteinyl 
leukotriene antagonists (Source: Steinhilber et al., 2010)
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Figure 18 Secondary metabolites of  Melicope ptelefolia showing 
a wide variety of compound classes
 Further tests on cyclooxygenases (COX) indicated that the 
compound acted via a dual LO/CO inhibitory mechanism, with 
greater selectivity for 5-LO and COX-2 (IC
50
 0.40 mM).	 	These 
types of phloroglucinols, therefore, are promising candidates for 
further drug development studies since dual inhibitors of both LO 
and COX enzymatic pathways are expected to be more effective 
as anti-inflammatory agents and are expected to have better safety 
profiles.  Thus. a more concerted effort to study the pharmacology 
of tHGA in experimental animal models of asthma was initiated in 
collaboration with another pharmacology group in UPM’s Faculty of 
Medicine and Allied Health.  Bulk synthesis of tHGA was initiated 
to provide gram quantities of the compound for the animal studies.
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 It is not the intention to detail out the ensuing pharmacology 
aspects of the work on tHGA in this section since the excellent 
work that followed ours deserves a different platform for 
discussion.  Suffice for us to mention here that, in summary, our 
findings regarding tHGA’s inhibitory effects upon cysLT synthesis 
in vitro have been confirmed in an established acute model of 
murine allergic airway inflammation. Doses as low as 2 mg/kg are 
therapeutically effective in alleviating all common parameters of 
pulmonary dysfunction in the animal model and it is possible that 
these effects are due solely to the inhibition of 5-LO enzyme activity 
and subsequent synthesis of cysLTs (Ismail et al., 2012).  What is 
more exciting to highlight is that the efficacy of tHGA seems to 
rival that of zileuton, the only 5-LO inhibitor approved for clinical 
use currently.  In contrast to tHGA, zileuton is a N-hydroxyurea 
derivative, and thus, most likely acts a iron-chelator at the active site 
of 5-LO, thereby blocking the enzyme’s redox potential (Dahlén, 
2006).  Nevertheless, better understanding of its effects upon other 
proinflammatory mediators and their signaling pathways is still 
needed before the true potential of tHGA as an anti-asthma drug 
lead is established.  Experiments are already underway to evaluate 
the effects of tHGA upon tissue remodeling in chronic models that 
better mimic human asthma. 
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Figure 21  Acute airway inflammation in OVA-treated mice – lung 
pathology following tHGA injections. Lung tissue (upper and lower 
lobes of left lung) of PBS-treated control mice (A, C) and OVA-
sensitized/challenged mice (B, D) was fixed in 10% buffered formalin 
and stained with hematoxylin and eosin (A, B) or Periodic Acid Schiff 
(C, D) and examined by light microscopy. Bar=100 μm.  Quantitative 
analysis of inflammatory cell infiltration (E) and goblet cell metaplasia 
(F). Data are expressed as mean±SEM. Significant difference from 
OVA-sensitized and challenged mice, ** Pb0.01, ***Pb0.001. Z+OVA 
= zileuton-treated group
UNPICKING MOLECULES TO CREATE BETTER 
ANALOGUES
Drug discovery is an iterative process of lead discovery, i.e. isolation 
of bioactive lead compounds from  natural sources, coupled with 
lead improvement, which involves rational design and synthesis 
of new analogues to improve pharmacological profiles. After 
selection of a new lead, drug development continues outside of 
the academic laboratories through preclinical studies comprising 
toxicology, formulation and production, followed by clinical trials. 
In the academic laboratory, drug design and structure modification 
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employs several tools to identify the optimum chemotherapeutic 
agent: (a) structure-activity relationship (SAR) studies including 
both qualitative and quantitative SAR, (b) mechanism of action 
studies including drug receptor interactions and specific enzyme 
inhibitions, (c) drug metabolism studies including identification 
of bioactive metabolites and blocking of metabolic inactivation, 
(d) molecular modeling studies including determination of 3D 
pharmacophores, and (e) combinatorial chemistry, including 
creation of peptide and nonpeptide libraries to generate new leads.
Enhancing the Anti-inflammatory Effects of tHGA
After the discovery of the drug-like molecule, tHGA, we further 
ventured into an SAR study of the acylphloroglucinol structural-
core, employing real and in silico docking experiments, to 
understand more about how such a molecule binds in the active 
site of the human 5-LO enzyme.  The ligand-receptor interaction 
of tHGA was investigated via molecular docking simulation studies 
(Khozirah et al., 2011b).  The results provided a preliminary insight 
into the way tHGA could be binding with the 5-LO enzyme. The 
hydroxy groups on the phloroglucinol moiety seemed to be an 
essential feature, where the hydroxy groups formed hydrogen bonds 
to the carboxylate group of isoleucine residue in the active pocket of 
the enzyme.  Strong Van der Waals interaction of the hydrophobic 
geranyl side chain of tHGA with several amino acid residues in the 
active site also indicated this to be an essential feature for bioactivity. 
 We had also observed that arachidonic acid and our compounds 
had similar structural features i.e a combination of a phloroglucinol 
core structure with a hydrophilic acyl group and a hydrophobic 
geranyl group.   The observed inhibitory action of these compounds 
on 5-LO indicated that the lipophilic geranyl group is important for 
the pharmacological activity.  The only difference between these 
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compounds was the nature of the acyl substituent.  This motivated 
us to carry out the synthesis of tHGA analogues where our strategy 
was straightforward, i.e modify the acyl group of the tHGA template 
but preserve the geranyl moiety that resembles the hydrophobic tail 
of arachidonic acid (Figure 22).   
 A series of tHGA analogues were successfully prepared and 
tested for their in vitro anti-inflammatory activities against soybean 
15-LO (Weckler, 2009).  The synthesized analogues exhibited 
moderate to excellent inhibitory activity in as dose-dependent 
manner, giving IC
50
 values ranging from10.3 to 27.6 μM.  The 
SAR study suggested that the elongation of the aliphatic chain of 
acyl moieties (3c and 3e) and introduction of aromatic moiety (3g) 
significantly improved inhibitory activity by 30 to 50%, as compared 
to tHGA.
Figure 22  IC
50 
values of naturally active LOX inhibitors in which the 
structure features are similar to that of arachidonic acid 
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Figure 23  Synthesis of analogues by two step synthesis from 
phloroglucinol by Friedel–Crafts acylation (R) followed by geranylation 
of the electron-rich benzene ring.  Reagents and conditions: (i) 
Acyl chloride, anhydrous aluminium chloride, hydrochloric acid, 
dichloromethane; (ii) Geranyl bromide (C
10
H
17
Br), anhydrous 
potassium carbonate, dry methanol, reflux 8 hrs. 
Table 4 Anti-inflammatory activities of phloroglucinol (1), tHGA 
analogues (3a, 3c, 3e-g), tHGA and NDGA on soybean 15-LOX 
enzyme
Compound
% Inhibition
(100 μg/mL)
IC
50
 value (μM)
Mean ± SEM
1 23.2 ± 2.2 > 100
3a 90.3  ± 4.1 27.61  ± 3.6
3c 94.4  ± 3.0 12.32  ± 0.6
3e 90.3  ± 4.4 10.31  ± 1.5
3f 88.8  ± 5.9 26.31  ± 1.3
3g 90.8  ± 7.6 15.20  ± 1.2
tHGA 94.3  ± 3.4 23.61  ± 1.7
NDGA 100  ± 0.0  ±  0.0
  NDGA (Nordihydroguaiaretic acid) as reference compound  
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We further carried out molecular docking studies to obtain better 
insight on the molecular interaction of the compounds in the 
active site, in the hope of identifying important structural features 
that influence the ligand-protein interactions between the tHGA 
analogues and the enzyme.  The 5-LO protein structure  retrieved 
from the Brookhaven Protein Data Bank (PDB) and Discovery 
Studio® 3.1 (Accelrys, San Diego, USA) was employed for the 
docking simulation and analysis.  The binding energy of the 
bioactive analogues obtained from the computer simulations 
correlated well with the bioassay results.  Molecular docking studies 
revealed that the bioactive compounds occupied  the receptor site by 
aligning itself in the same maner as (9Z,11E)-13(R)-hydroperoxy-
9,11-octadecadienoic acid (13-HPOD), the original co-crystallized 
ligand in the ligand-protein complex crystal structure.  Thus, it is 
suggested that the enzyme inhibition could be through competitive 
inhibition.  The significant improvement in the bioactivities of these 
acylphloroglucinol analogues are worthy of further pharmacological 
evaluation and lead optimization as potential LO inhibitors.  Further 
work is being planned to further evaluate the inhibitory effects of 
the bioactive tHGA analogues on experimental animal models of 
inflammation.
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Figure 24 Three-dimensional (3D) docking model of  binding 
interaction of the compound with amino acid residues: (a) Compound 
3e; (b) tHGA; The atom colouring for the compounds is the following: 
carbons in grey, oxygen in red, nitrogen in blue, hydrogen in white and 
amino acid in green color. The orange line indicates the π-interaction, 
while the green line indicates the hydrogen-bonding interactions
Figure 25  Three-dimensional (3D) docking model of the overlaying 
pose between the most active compound 3e with the (9Z, 11E)-13(R)-
hydroperoxy-9,11-octadecadienoic acid (13-HPOD) as LOX substrate. 
The grey color represents compound 3e, while yellow sticks represents 
13-HPOD, with distance indicated in angstroms, (Å)
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MEETING THE METABOLOMICS CHALLENGE
Metabolomics is an approach which provides an essentially 
unbiased, comprehensive qualitative and quantitative overview of 
the metabolites present in an organism.  It is often used in plant 
research.  Meanwhile, metabonomics is used when refering to 
the same approach but on non-plants, to quantitatively measure 
the metabolic composition of body fluids following a response 
to pathophysiological stimuli.  Metabolic analysis can be divided 
into four areas, i.e. target compound analysis (the quantification 
of specific metabolites), metabolic profiling (quantitative and 
qualitative determination of a group of related compounds 
or of specific metabolic pathways, metabolomics (qualitative 
and quantitative analysis of all metabolites) and metabolomic 
fingerprinting (sample classification by rapid global analysis). 
It uses several powerful platforms for data acquisition, such as, 
nuclear magnetic resonance (NMR) and LCMS spectroscopy, in 
combination with multivariate analysis to discern discriminating 
phenotype  patterns  and to gain holistic insights on the biological 
response resulting from external perturbations.  
 The application of the ‘‘-omic-’’ technologies have led to a 
change in paradigms towards the application of complex mixtures 
in medicine.  The combined technologies in phytogenomics, 
proteomics and metabolomics substantially increase the number 
of proteins/genes/metabolites that can be detected simultaneously 
and have the potential to relate complex mixtures to complex 
effects in the form of gene/protein expression/metabolite profiles. 
These technologies have great potential for the chemical and 
pharmacological standardization and  providing proof of the 
toxicological potential and the efficacy of a medicinal plant extract.
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Centella’s Story
One of my mother’s favorite ulam is ‘pegaga’.  In fact, most of the 
Malays in this country will know this little perennial and evergreen 
creeper, which to some is a secret to being ‘awet muda’ i.e youthful 
(Burkill, 1966).  The plant is also featured in Ayurvedic and 
Traditional Chinese Medicine systems as a tonic for maintaining 
youthfulness, longevity and enhancing memory as well as a herbal 
remedy for a wide range of applications which include treatment 
of skin diseases, varicose veins, arthritis and wound healing (De 
Padua and Bunyapraphatsara, 1999).  Currently, pegaga extract is 
added to cosmetics for its anti-ageing properties, specifically for 
ameliorating lines and wrinkles, prophylactically treating loss of 
elasticity (Oblong and Bissett, 1997), improving keratinocytes 
differentiation and for enhancing epidermal functionality.  It is also 
a dermatologically effective phytotherapeutic agent that has been 
used in the form of complex homeopathic preparations, such as an 
ointment for external application.  This plant apparently has the 
ability to inhibit a group of enzymes that break down collagen while 
simultanously increasing the rate at which collagen is synthesized, 
which is thought to underlie the increased wound healing rate (which 
has been proven in animal research).  This is thought to be the reason 
why pegaga is used as a skin tightening agent as any increase in 
collagen synthesis will cause a firmness of the skin.  Apart from 
these uses, the Malays also believe that pegaga has excellent anti-
diabetic properties for which some scientific evidence has been 
reported in recent years (Kabir et al, 2014).
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Figure 26  Different varieties of pegaga. Left – Centella asiatica var 
1, top middle – C. asiatica var 2, top right – C. asiatica var 3, bottom 
middle – Hydrocotyle bonariensis, bottom right – H. sibthorpiodes
 Several varieties of Pegaga are known, viz. C. asiatica (pegaga 
kampong), Hydrocotyle bonariensis (pegaga nyonya) and H. 
sibthorpioides (pegaga embun) (Figure 26).  Although C. asiatica 
seems to be related to the Hydrocotyle species, and has been 
classified in the same subfamily as Hydrocotyle bonariensis and H. 
sibthorpioides Lam., its morphological, anatomical, palynological 
and phytochemical characteristics retain it in the genus Centella 
(Downie et al., 1996). All of the varieties are edible, but some are 
more favored over others for a certain use.  For example pengaga 
nyonya is good for juicing and pegaga kampong and embun to make 
‘kerabu’, a healthy traditional salad.  Despite its popular use, a great 
deal of uncertainly still exist with regards to the differences between 
the Pegaga varieties, which present problems in the quality control 
and standardization of the plant material for  use in downstream 
products.   It raises questions such as, which pegaga variety is the 
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right or most effective one for a specific use?  Do all the varieties 
work indiscriminately or are the effects different for each variety? 
If this is true what are the differences in the metabolome of each 
variety that acts as the discriminating factor in their biological 
properties?  In an attempt to answer these questions, our group 
embarked on an NMR-based metabolomics study of the three 
distinctive varieties of pegaga.   
 Metabolite fingerprinting using 1H NMR in combination with 
multivariate data analysis, (PCA and HCA), allowed discrimination 
of the Pegaga varieties into three clusters (Maulidiani et al., 2012). 
The study revealed that asiaticoside and madecassoside along 
with chlorogenic acids were the metabolites contributing to the 
separation of C. asiatica, H. bonariensis and H. sibthorpiodes 
extracts (Figures 27 – 29).  The two triterpene glycosides were only 
detected in C. asiatica extracts but not in the H. bonariensis, and H. 
sibthorpioides extracts.  These compounds are well known to exhibit 
important biological activities, including antioxidant, anticancer 
and anti-inflammation (Al-Saeedi et al., 2011; Wan et al., 2012). 
Thus, we  established the phytochemical relationship between the 
varieties, which could be applied in the selection of varieties for 
specific phytomedicinal use and to establish the standard fingerprint 
targeted for this purpose.  
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Figure 27  1H NMR Spectra (CD
3
OD+ 0.2% TMS) of methanolic extract 
of H. sibthorpioides (A), H. bonariensis (B), and C. asiatica (C). Identified 
signals:  1. kaempferol derivatives; 2. dicaffeoyl quinic acid derivatives; 3. 
quercetin derivatives;  4. sucrose; 5. asiaticoside/madecassoside; 6. α-glucose; 
7. β-glucose;  8. choline; 9. fatty acids
Figure 28  Two dimensional score (A) and loading (B) plots of the principal 
component analysis (PCA) separated by PC1 and PC2 of the methanolic 
extracts of C. asiatica, H. bonariensis  and H. sibthorpioides. Score plot (A) 
shows the discrimination of three Pegaga varieties. Loading plots (B) indicate 
the 1H NMR signals of compounds that are responsible for the separation of the 
three Pegaga varieties including sucrose at δ
H
 5.4 (d, J = 4.0 Hz); asiaticoside at 
5.24 (t, J= 3.5 Hz), 1.12 (s), 1.08 (s), 0.72 (s); dicaffeoyl quinic acid derivatives 
at 7.08 (d, J= 2.0 Hz), 6.96 (dd, J= 8.0, 2.0 Hz); kaempferol derivatives at 8.08 
(d, J=8.0 Hz), 6.88 (d, J=8.0 Hz); and quercetin derivatives at 7.64 (dd, J=8.5, 
2.0 Hz), 6.36 (d, J=1.5 Hz), 6.16 (d, J=2 Hz)
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Figure 29  LC-DAD-ESIMS/MS (-ve ion mode) TIC profiles of the 
ethanolic extracts of (A) C. asiatica, (B) Hydrocotyle bonariensis, 
and (C) H. sibthorpioides. (Madecassoside (21)  Asiaticoside B (23) 
Centellasaponin A (26) Asiaticoside (28) Madecassic acid (37) Asiatic 
acid (39)
 Pushing the limits a little further, we carried out a metabonomics 
study on pegaga species to understand their anti-diabetic effects. 
One of the traditional medicinal uses of pegaga is in treating 
diabetes mellitus (Semenya et al., 2012). Several scientific studies 
have also reported the anti-hyperglycemic activity of pegaga in 
diabetic rat models (Zheng et al., 2011; Kabir et al., 2014).   Our 
question was which pegaga variety exerts the effect?  
 For the study, an obese-diabetic rat model was  developed using 
non-genetic out-bred Sprague–Dawley rats fed with high fat diet 
and diabetes-induced with a low-dose of streptozotocin followed 
by treatment with the plant extract (Figure 30).  Subsequently, the 
metabolic changes in the biofluids of the rats fed with the plant 
extract were followed by analyzing the 1H NMR spectrum of their 
urine and blood samples.  
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 A PCA-model was fitted to the bucketed NMR spectra of urine 
samples collected from normal (nd) and obese rats before injection 
with STZ (ob, initial), after injection with STZ (obdb, baseline), 
and from  the plant extract-treated obdb groups (C. asiatica and 
H. bonariensis) as well as metformin-treated obdb group  (middle 
and final).  The individual score plots final timepoints (blue) and 
trajectory changes from initial (red), base (green), middle (yellow) 
to final timepoints, resulting from treatments with metformin and 
plant extracts are shown in Figure 31.  
Figure 30  Experimental design for Type 2 diabetes mellitus animal 
model study to evaluate anti-diabetic effects of C. asiatica and H. 
bonariensis
 The movement of the trajectory from the initial to the left 
(A) along the first principal component after diabetes-induction 
indicated signif icant metabolic changes and/or metabolic 
disturbances in the animals, clearly reflecting the effect of the STZ 
injection. Following treatments with C. asiatica extract (B) it was 
observed that the trajectory showed a reversal of the treated rats back 
to  normal state whereas treatment with H. bonariensis (C) did not 
show a similar reversal. This indicated that  long term treatment with 
C. asiatica extract restored the metabolic disturbances back to the 
normal state whereas a similar effect was not shown in the treatment 
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with H. bonariensis extract.  Further, it appeared that  long term 
treatment with metformin (D) seemed to exert a different effect on 
the metabolic conditions of the obdb rats.  Although glucose levels 
were lowered, creatinine levels had somehow been elevated!
 A detailed analysis of the PCA loadings showed that long term 
treatment with C. asiatica extract could reverse glucose, lipid, 
tricarboxylic acid cycle, and amino acid metabolic disorders back 
towards normal state.  It is interesting to note also that long term 
treatment with metformin had altered some of the metabolism 
of the animal models.  However, this study is just a brief look 
into the metabonomics of the in vivo effects.  The observations 
made in this study have answered some of our initial questions 
but, at the same time, it has raised new ones which deserve more 
thorough pharmacological studies.  As far as our objectives are 
concerned, the results have provided evidence that C. asiatica has 
anti-hyperglycemic and anti-antihyperlipidemic effects, and may 
perhaps be very beneficial for use in managing the complications 
arising from diabetes mellitus.   Metabolomics, and in this particular 
case, NMR-based, has been proven to be a very useful and holistic 
approach towards providing scientific evidence of the use and value 
of medicinal plants.
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Figure 31  PCA score for (a) control, trajectory (b) treatment with 
metformin, (c) C. asiatica and (d) H. bonariensis extracts and (e) PCA 
loading plots of the 1H NMR data 
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BACK TO THE FUTURE
A renaissance in the exploitation of nature´s resources has been 
witnessed in the last few years because plants still provide a vast 
resource of structural complex and diverse molecules with a broad 
range of desired functions, many of which still remain elusive unless 
suitable assays can be developed to identify them. It is evident 
that natural products research is interdisciplinary and requires 
that collaboration exists between different scientific disciplines, 
including botany, biochemistry, pharmacognosy, pharmacology, 
phytochemistry, medicine, toxicology and biotechnology. 
Pharmacognosy, based for many years in botanical methodology, 
embraced phytochemistry and the new, powerful and sensitive 
methods of analysis for identifying, characterising and determining 
chemical structures of natural products. The parallel developments 
of sensitive methods for assessing biological activities enables 
research to focus on the active constituents of plants. The creative 
approaches that can be used alongside these facilities  provide 
an excellent platform for researchers in the various disciplines to 
congregate and work together better in pursuit of the main goal 
of finding future cures.  It must be recognized that there are still 
numerous plants of value which might be brought to commerce for 
the benefit of mankind and our goal is to find them, demonstrate 
their safety and efficacy.  To realize this great promise effectively, 
we need a ‘‘systems’’ approach which applies careful coordination 
of the entire process of discovery and development.  Finally, natural 
products research as a whole is enriched by both phytochemistry and 
metabolomics approaches as useful tools and will remain an exciting 
subject for research.   It cannot be denied that the identification of 
structural diversity and biological activity of natural products are 
essential routes to finding new pharmaceutical leads.  Sustainable 
and cost-effective production systems for high-value plant-derived 
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compounds must be developed, and the best outcome can be 
achieved by integrating scientifically-based approaches and sound 
methodologies into more sustainable production chains featuring 
cutting-edge innovative technologies.  Deforestation issues and 
ecosystem changes are current threats which will still be there in 
the immediate future.  Humankind is in a race against time before 
these valuable resources are forever lost.  Thus,  its exploration 
needs to continue, especially for the discovery of new molecules and 
potential drug leads to alleviate or cure current and future diseases. 
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 Her dream for the future is to continue contributing her 
knowledge and expertise to young researchers and to help raise 
Natural Products Research in this country to greater heights.
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